1217 GMT - Fresenius Medical Care investors might be disappointed by a smaller-than-expected increase in 2027 payment rates proposed by the U.S. Centers for Medicare & Medicaid Services, UBS analysts say in a research note. The CMS on Wednesday said it proposed to increase payments to facilities where Medicare beneficiaries with end-stage renal disease get dialysis services by 1.1% next year. The proposed raise for the base rate is roughly half of what investors likely anticipated and well below prior years, according to UBS. Shares in Fresenius Medical Care fall 2.8%. (adria.calatayud@wsj.com)
(END) Dow Jones Newswires
June 25, 2026 08:17 ET (12:17 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.